Balamurugan Tangiisuran, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pharmacists | 3 | 2020 | 256 | 1.290 |
Why?
|
Malaysia | 15 | 2022 | 106 | 1.150 |
Why?
|
Community Pharmacy Services | 1 | 2020 | 50 | 0.710 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 3966 | 0.710 |
Why?
|
Household Products | 1 | 2018 | 27 | 0.670 |
Why?
|
Nonprescription Drugs | 1 | 2020 | 117 | 0.670 |
Why?
|
Accidents | 1 | 2018 | 164 | 0.610 |
Why?
|
Poisoning | 1 | 2018 | 253 | 0.590 |
Why?
|
Medication Therapy Management | 1 | 2017 | 129 | 0.550 |
Why?
|
Pesticides | 1 | 2018 | 291 | 0.540 |
Why?
|
Intention | 1 | 2018 | 346 | 0.540 |
Why?
|
Nursing Staff | 1 | 2017 | 130 | 0.540 |
Why?
|
Inappropriate Prescribing | 2 | 2014 | 210 | 0.470 |
Why?
|
Long-Term Care | 1 | 2017 | 611 | 0.440 |
Why?
|
Medication Adherence | 3 | 2019 | 2099 | 0.430 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 980 | 0.410 |
Why?
|
Hypoglycemia | 1 | 2019 | 862 | 0.410 |
Why?
|
Delphi Technique | 1 | 2015 | 798 | 0.400 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7269 | 0.400 |
Why?
|
Hyperglycemia | 1 | 2019 | 1380 | 0.360 |
Why?
|
Poisons | 2 | 2022 | 36 | 0.360 |
Why?
|
Nursing Homes | 2 | 2014 | 1044 | 0.340 |
Why?
|
Attitude of Health Personnel | 4 | 2017 | 3871 | 0.310 |
Why?
|
Guideline Adherence | 2 | 2015 | 2295 | 0.290 |
Why?
|
Nigeria | 2 | 2020 | 764 | 0.290 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 2975 | 0.280 |
Why?
|
Hospitalization | 5 | 2016 | 10422 | 0.280 |
Why?
|
Caregivers | 1 | 2017 | 2149 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2191 | 0.250 |
Why?
|
Physicians | 2 | 2021 | 4625 | 0.250 |
Why?
|
Disease Management | 1 | 2015 | 2473 | 0.240 |
Why?
|
Cross-Sectional Studies | 9 | 2020 | 25454 | 0.220 |
Why?
|
Models, Theoretical | 1 | 2014 | 3586 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 11909 | 0.190 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7766 | 0.190 |
Why?
|
Drug Prescriptions | 2 | 2010 | 1651 | 0.180 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2017 | 478 | 0.180 |
Why?
|
Nicotinic Agonists | 1 | 2022 | 272 | 0.180 |
Why?
|
Polypharmacy | 1 | 2021 | 298 | 0.170 |
Why?
|
Legislation, Drug | 1 | 2020 | 210 | 0.160 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2022 | 625 | 0.150 |
Why?
|
Drugs, Chinese Herbal | 1 | 2019 | 146 | 0.150 |
Why?
|
Algorithms | 2 | 2017 | 13984 | 0.130 |
Why?
|
Homes for the Aged | 1 | 2017 | 263 | 0.120 |
Why?
|
Perception | 2 | 2019 | 1199 | 0.120 |
Why?
|
Antidepressive Agents | 2 | 2017 | 2863 | 0.120 |
Why?
|
Quality of Life | 2 | 2019 | 13044 | 0.110 |
Why?
|
Sex Distribution | 1 | 2018 | 2304 | 0.110 |
Why?
|
Aged | 13 | 2021 | 165629 | 0.110 |
Why?
|
Male | 18 | 2020 | 354311 | 0.110 |
Why?
|
Needs Assessment | 1 | 2018 | 1151 | 0.110 |
Why?
|
Databases as Topic | 1 | 2014 | 475 | 0.110 |
Why?
|
Nutritional Support | 1 | 2014 | 170 | 0.100 |
Why?
|
Qualitative Research | 1 | 2021 | 2778 | 0.100 |
Why?
|
Humans | 26 | 2022 | 752741 | 0.100 |
Why?
|
Female | 18 | 2020 | 385090 | 0.100 |
Why?
|
Inpatients | 3 | 2017 | 2549 | 0.100 |
Why?
|
Geriatric Assessment | 2 | 2017 | 1390 | 0.100 |
Why?
|
Prevalence | 3 | 2019 | 15404 | 0.100 |
Why?
|
General Practitioners | 1 | 2012 | 106 | 0.090 |
Why?
|
Heart Failure | 1 | 2015 | 11096 | 0.090 |
Why?
|
Nutrition Assessment | 1 | 2014 | 729 | 0.090 |
Why?
|
Professional Competence | 1 | 2014 | 449 | 0.090 |
Why?
|
Medication Reconciliation | 1 | 2012 | 153 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2017 | 58361 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2297 | 0.080 |
Why?
|
Depressive Disorder, Major | 2 | 2017 | 4692 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2022 | 78758 | 0.080 |
Why?
|
Hospitals, University | 1 | 2010 | 576 | 0.080 |
Why?
|
Europe | 1 | 2014 | 3359 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2083 | 0.070 |
Why?
|
Malnutrition | 1 | 2014 | 631 | 0.070 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1183 | 0.070 |
Why?
|
Prospective Studies | 5 | 2020 | 53863 | 0.070 |
Why?
|
Stroke | 2 | 2020 | 10152 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8413 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2020 | 3284 | 0.070 |
Why?
|
Risk Factors | 8 | 2020 | 73094 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1180 | 0.070 |
Why?
|
Middle Aged | 9 | 2020 | 216054 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39223 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4624 | 0.060 |
Why?
|
Continuity of Patient Care | 1 | 2012 | 1056 | 0.060 |
Why?
|
Comorbidity | 2 | 2019 | 10450 | 0.060 |
Why?
|
Incidence | 2 | 2020 | 21146 | 0.060 |
Why?
|
Patient Discharge | 2 | 2016 | 3356 | 0.060 |
Why?
|
Recurrence | 3 | 2020 | 8422 | 0.050 |
Why?
|
Anxiety | 1 | 2016 | 4395 | 0.050 |
Why?
|
Risk Assessment | 4 | 2020 | 23554 | 0.050 |
Why?
|
Adult | 7 | 2022 | 216658 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3077 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12250 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7008 | 0.050 |
Why?
|
Child, Preschool | 2 | 2022 | 41390 | 0.050 |
Why?
|
Quinoxalines | 1 | 2022 | 288 | 0.050 |
Why?
|
Bupropion | 1 | 2022 | 310 | 0.050 |
Why?
|
Benzazepines | 1 | 2022 | 320 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20026 | 0.040 |
Why?
|
Epirubicin | 1 | 2019 | 81 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29264 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11626 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12868 | 0.040 |
Why?
|
Hypertension | 2 | 2020 | 8614 | 0.040 |
Why?
|
Depression | 1 | 2016 | 7876 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2019 | 485 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7355 | 0.030 |
Why?
|
Fluorouracil | 1 | 2019 | 1633 | 0.030 |
Why?
|
Registries | 2 | 2020 | 8216 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1087 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2252 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2573 | 0.030 |
Why?
|
Personnel, Hospital | 1 | 2014 | 288 | 0.030 |
Why?
|
Child | 1 | 2020 | 78594 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20914 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2012 | 249 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8752 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2020 | 2152 | 0.020 |
Why?
|
Hospital Administration | 1 | 2012 | 353 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40195 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3861 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2022 | 64017 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4077 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10469 | 0.020 |
Why?
|
Nutritional Status | 1 | 2014 | 1610 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9030 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11091 | 0.010 |
Why?
|
Medication Errors | 1 | 2010 | 799 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14219 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3618 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12821 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25903 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1842 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3161 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14761 | 0.010 |
Why?
|
Hospitals | 1 | 2014 | 3986 | 0.010 |
Why?
|
Infant | 1 | 2022 | 35447 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40939 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13364 | 0.010 |
Why?
|
Mass Screening | 1 | 2014 | 5282 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 86713 | 0.010 |
Why?
|